Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial

Published:2013-06-27 Issue:1 Volume:13 Page:
ISSN:1471-244X
Container-title:BMC Psychiatry
language:en
Short-container-title:BMC Psychiatry

Author:

Tek Cenk,Guloksuz Sinan,Srihari Vinod H,Reutenauer Erin L

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1186/1471-244X-13-176.pdf

Reference62 articles.

1. Phutane VH, Tek C, Chwastiak L, Ratliff JC, Ozyuksel B, Woods SW, Srihari VH: Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?. Schizophr Res. 2011, 127 (1–3): 257-261.

2. Chwastiak LA, Tek C: The unchanging mortality gap for people with schizophrenia. Lancet. 2009, 374 (9690): 590-592. 10.1016/S0140-6736(09)61072-2.

3. Ratliff JC, Palmese LB, Reutenauer EL, Srihari VH, Tek C: Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness. Psychosomatics. 2013, 54 (1): 67-73. 10.1016/j.psym.2012.03.001.

4. Newcomer JW, Hennekens CH: Severe mental illness and risk of cardiovascular disease. JAMA. 2007, 298 (15): 1794-1796. 10.1001/jama.298.15.1794.

5. Jones DR, Macias C, Barreira PJ, Fisher WH, Hargreaves WA, Harding CM: Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv. 2004, 55 (11): 1250-1257. 10.1176/appi.ps.55.11.1250.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of naltrexone-induced acute eosinophilic pneumonia;BMJ Case Reports;2024-05

2. Psychotropic Drug–Related Weight Gain and Its Treatment;American Journal of Psychiatry;2024-01-01

3. Nutrition and schizophrenia: associations worthy of continued revaluation;Nutritional Neuroscience;2023-08-11

4. Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?;Expert Review of Neurotherapeutics;2022-09-02

5. Antipsychotic‐induced weight gain: Is the weight over? New guidelines needed;Acta Psychiatrica Scandinavica;2022-08-11